Contributors: Dr. Adrian Lau, Dr. Claudia Gagnon, Dr. Laëtitia Michou, Dr. Emma Billington, Dr. Zahra Bardai, Dr. Dr. Vithika Sivabalasundaram, Dr. Rowena Ridout, Dr. Sandra Kim, Dr. Suzanne Morin Recommendations […]
Since the COVID-19 lockdown began and even now as things begin to open up across the country, many health professionals have been consulting with their patients on-line or on the […]
We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]
We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]
Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]
Aliya Khan, Heather Frame, Claudia Gagnon, Rowena Ridout , Lianne Tile, Wendy Ward, Sandra Kim Recently Duerksen and colleagues published on fracture risk assessment in celiac disease – a registry-based […]
PRESS RELEASE TORONTO, November 19, 2020 – Dr. Earl Bogoch has been appointed the inaugural holder of the Brookfield Chair in Fracture Prevention. Dr. Famida Jiwa, President & CEO, Osteoporosis […]
Legal The information on this site has been developed by Osteoporosis Canada in consultation with its Scientific Advisory Council. This Council is composed of leading Canadian medical and scientific experts […]
